Markets
News
Analysis
Tools
Learn
Features
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Sign Up
Sign Up
News
All
Editors' Picks
Forex
Commodities
Stocks
Indices
Cryptocurrencies
Technical Analysis
Economic Indicator
Other
Important Only
Dollar General lifts annual targets on strong demand for cheaper essentials
Aug 28 (Reuters) - Dollar General DG.N raised its annual sales and profit forecasts on Thursday, banking on steadfast demand from cost-conscious consumers across income brackets in the United States amid tariff and inflation concerns.The company's shares rose about 6% in premarket trading and th...
Reuters
8 minutes ago
SOFTS-Robusta coffee turns lower after touching three-month high
LONDON, Aug 28 (Reuters) - Robusta coffee futures turned lower on Thursday after hitting a three-month peak, though prices remained underpinned by a further decline in exchange stocks. COFFEE* Robusta coffee futures LRCc2 lost 1.6% to $4,798 a metric ton by 1111 GMT after setting a three-mont...
Reuters
10 minutes ago
CANADA STOCKS-TSX futures muted; lenders TD Bank and CIBC post upbeat results
Aug 28 (Reuters) - Futures tied to Canada's main stock index were subdued on Thursday, while TD Bank and CIBC became the latest domestic lenders to report a rise in third-quarter profit.Futures on the S&P/TSX index .SXFcv1 fell 0.05% by 06:59 a.m. ET (1007 GMT) following the composite index&...
Reuters
15 minutes ago
Citigroup raises PT on Cheniere Energy
** Citigroup raises price target of LNG exporter Cheniere Energy LNG.N to $283 from $275** The new price target represents an upside of 17.1% to the stock's last close** Brokerage raises PT to reflect lower cash tax assumptions that are boosting cash flows estimates** Beyond 2025, Cheniere expec...
Reuters
15 minutes ago
Apollomics tumbles as cash crunch forces layoffs, trial shutdown
** Shares of Apollomics APLM.O fall 16.5% to $5.20 premarket** The biotech firm has terminated all U.S. staff, including its CEO and CFO, due to cash constraints, it said in a SEC filing ** Co also plans to halt all activities related to its lung cancer trial** Last year, co said its blood cancer th...
Reuters
16 minutes ago
GMS Inc reports results for the quarter ended July 31 - Earnings Summary
GMS Inc GMS.N reported quarterly adjusted earnings of $1.76 per share for the quarter ended July 31, lower than the same quarter last year, when the company reported EPS of $1.93. The mean expectation of nine analysts for the quarter was for earnings of $1.72 per share. Wall Street expected resul...
Reuters
19 minutes ago
US STOCKS-Nasdaq futures flat as Nvidia slips on China market uncertainty
Futures: Dow up 0.13%, S&P 500 down 0.02%, Nasdaq off 0.08%Snowflake surges on AI-driven revenue forecastCrowdStrike falls on weak revenue forecastDollar General up after lifting annual targets on strong demandBy Johann M Cherian and Sanchayaita Roy Aug 28 (Reuters) - Futures tracking the te...
Reuters
20 minutes ago
BTIG initiates coverage on NANO Energy with 'neutral' rating
** BTIG initiates coverage on nuclear technology company NANO Nuclear Energy NNE.O with "neutral" rating** BTIG did not provide a PT for NNE; shares of the company up nearly 1% at $33.20 premarket** "We like NNE's micro reactor solution which should compete against other small modula...
Reuters
23 minutes ago
ASR Microelectronics's Shareholder To Unload Up Shares
Aug 28 (Reuters) - ASR Microelectronics Co Ltd 688220.SS:SAYS SHAREHOLDER ALIBABA (CHINA) NETWORK TECHNOLOGY PLANS TO UNLOAD UP TO 3% STAKE IN COSource textFurther company coverage: 688220.SS
Reuters
26 minutes ago
Burlington EPS Jumps 43% in Fiscal Q2
Key PointsAdjusted earnings per share jumped 39% year over year, well ahead of company forecasts.Full-year adjusted EPS guidance was raised, but management remains cautious about the second half.These 10 stocks could mint the next wave of millionaires › Burlington Stores (NYSE:BURL), a major off-pri...
The Motley Fool
27 minutes ago
1 Reason to Buy RELY
Key PointsDue to the nature of the company's business and its tight focus, tracking Remitly's progress is relatively straightforward.It takes a cut of each transaction made by customers, so raising total volume is critical for growth.10 stocks we like better than Remitly Global › International remit...
The Motley Fool
28 minutes ago
LIVE MARKETS-Foreign investors on sidelines in ASEAN equity rally - for now
STOXX 600 down 0.3% Pernod Ricard up 5% after results Nvidia shares fall 2.2% in U.S. pre market after resultsS&P 500 futures flatWelcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com....
Reuters
31 minutes ago
Snowflake shares surge as AI boom fuels demand for data platforms
By Akash Sriram Aug 28 (Reuters) - Snowflake SNOW.N shares jumped about 14% on Thursday riding a wave of demand for its artificial intelligence database products, as companies race to modernize their data infrastructure and simplify AI adoption.The stock move is set to add more than $11 billion t...
Reuters
35 minutes ago
5 Things to Know About Coca-Cola Stock Before You Buy
Key PointsThe iconic beverage maker boasts 63 consecutive years of dividend increases.Coca-Cola Zero Sugar is the company's fastest-growing brand by a wide margin.It's willing to adjust to the times, eliminating some 200 brands a few years ago.10 stocks we like better than Coca-Cola › There's a stro...
The Motley Fool
37 minutes ago
Tech, utilities drag UK stocks lower
FTSE 100 down 0.5%, FTSE 250 slips 0.5%Drax Group slumps after financial watchdog probe PPHE Hotel drops after HY earningsIT firm Softcat gains on annual forecast lift Aug 28 (Reuters) - UK's blue-chip and midcap stocks fell for a third consecutive session on Thursday, with utilities and tech...
Reuters
38 minutes ago
Telomir Pharma surges on early data for epigenetic drug
** Shares of drug developer Telomir Pharmaceuticals TELO.O surges 59% to $2.35 premarket** Late Wednesday, co said lead experimental drug, Telomir-1, shows potential as first-in-class epigenetic therapy for cancer, age-related diseases** Co says it effectively blocks UTX, a gene regulation enzyme, a...
Reuters
43 minutes ago
Prediction: These 3 Stocks Will Be Worth More Than Tesla 10 Years From Now
Key PointsEach of these companies has a great track record and great potential.They're not all bargain-priced right now, though. They will need to execute their strategies well to top Tesla's possible future value -- but so will Tesla.10 stocks we like better than Costco Wholesale › The funny thing ...
The Motley Fool
45 minutes ago
Have $500? 4 Absurdly Cheap Stocks Long-Term Investors Should Buy Right Now.
Key PointsOllie's Bargain Outlet sits at a nice place within the discount retail sector.The Campbell's Company offers value to consumers in a time of higher food prices.Vita Coco and Pinterest have strong financials and seem in a good position to strengthen.10 stocks we like better than Ollie's Barg...
The Motley Fool
50 minutes ago
Outlook Therapeutics slumps after US FDA declines to approve drug for eye condition
** Shares of Outlook Therapeutics OTLK.O slump 66.8% to 78 cents premarket** U.S. FDA declines to approve co's drug for a type of eye condition called wet age-related macular degeneration (wet AMD) that causes blurred vision ** OTLK says the FDA's letter included only one deficiency - a lack...
Reuters
51 minutes ago
US FDA declines to approve Outlook Therapeutics' drug for eye condition
Aug 28 (Reuters) - Outlook Therapeutics OTLK.O said on Thursday the U.S. Food and Drug Administration has declined to approve its experimental drug to treat a type of eye condition, which causes blurred vision, sending its shares slumping nearly 62% before the bell.The health regulator cited a lack ...
Reuters
52 minutes ago
1
1
/
3937
2
3
4
5
...
3937
next page
KeyAI
Please log in to use KeyAI
Log in
Sign Up